Raltitrexed

CAS No.

112887-68-0

MDL No.

MFCD00864168

C₂₁H₂₂N₄O₆S

458.50

InChI Key

IVTVGDXNLFLDRM-HNNXBMFYSA-N

Pack Size	Purity	Price	Availability
1 mg	98%	$8	In Stock
10 mg	98%	$12	In Stock
25 mg	98%	$22	In Stock
50 mg	98%	$32	In Stock
250 mg	98%	$115	In Stock
1 g	98%	$287	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

98%

In Stock

10 mg

98%

$12

In Stock

25 mg

98%

$22

In Stock

50 mg

98%

$32

In Stock

250 mg

98%

$115

In Stock

1 g

98%

$287

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

ICI D1694 is an N-acyl-amino acid.

CAS No.	112887-68-0
Product Name	Raltitrexed

Biological Targets

TYMS

Associated Conditions

esophageal squamous cell carcinoma·nasopharyngeal carcinoma·pancreatic carcinoma·mesothelioma·squamous cell carcinoma·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Raltitrexed

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells.

The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase.

Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.

Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.

Documentation